参考文献:1.Tol J, Roks G, Slooter AJ, van Duijn CM (1999) Genetic and environmental factors in Alzheimer’s disease. Rev Neurol (Paris) 155(Suppl 4):S10–S16 2.Yoshizawa T, Yamakawa-Kobayashi K, Komatsuzaki Y, Arinami T, Oguni E, Mizusawa H et al (1994) Dose-dependent association of apolipoprotein E allele epsilon 4 with late-onset, sporadic Alzheimer’s disease. Ann Neurol 36:656-59CrossRef PubMed 3.Roses AD, Saunders AM (1994) APOE is a major susceptibility gene for Alzheimer’s disease. Curr Opin Biotechnol 5:663-67CrossRef PubMed 4.Daw EW, Payami H, Nemens EJ, Nochlin D, Bird TD, Schellenberg GD et al (2000) The number of trait loci in late-onset Alzheimer disease. Am J Hum Genet 66:196-04PubMed Central CrossRef PubMed 5.Su JH, Anderson AJ, Cribbs DH, Tu C, Tong L, Kesslack P et al (2003) Fas and Fas ligand are associated with neuritic degeneration in the AD brain and participate in beta-amyloid-induced neuronal death. Neurobiol Dis 12:182-93CrossRef PubMed 6.Dang TN, Arseneault M, Murthy V, Ramassamy C (2010) Potential role of acrolein in neurodegeneration and in Alzheimer’s disease. Curr Mol Pharmacol 3:66-8CrossRef PubMed 7.Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA et al (2000) Caspase-12 mediates endoplasmic-reticulum-specific apoptosis and cytotoxicity by amyloid-beta. Nature 403:98-03CrossRef PubMed 8.Su JH, Anderson AJ, Cummings BJ, Cotman CW (1994) Immunohistochemical evidence for apoptosis in Alzheimer’s disease. NeuroReport 5:2529-533CrossRef PubMed 9.Richartz E, Noda S, Schott K, Gunthner A, Lewczuk P, Bartels M (2002) Increased serum levels of CD95 in Alzheimer’s disease. Dement Geriatr Cogn Disord 13:178-82CrossRef PubMed 10.Martinez M, Fernandez-Vivancos E, Frank A, De la Fuente M, Hernanz A (2000) Increased cerebrospinal fluid fas (Apo-1) levels in Alzheimer’s disease. Relationship with IL-6 concentrations. Brain Res 869:216-19CrossRef PubMed 11.de la Monte SM, Sohn YK, Wands JR (1997) Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer’s disease. J Neurol Sci 152:73-3CrossRef PubMed 12.Nishimura T, Akiyama H, Yonehara S, Kondo H, Ikeda K, Kato M et al (1995) Fas antigen expression in brains of patients with Alzheimer-type dementia. Brain Res 695:137-45CrossRef PubMed 13.Andreoli V, Nicoletti G, Romeo N, Condino F, La Russa A, Liguori M et al (2007) Fas antigen and sporadic Alzheimer’s disease in Southern Italy: evaluation of two polymorphisms in the TNFRSF6 gene. Neurochem Res 32:1445-449CrossRef PubMed 14.Chiappelli M, Nasi M, Cossarizza A, Porcellini E, Tumini E, Pinti M et al (2006) Polymorphisms of fas gene: relationship with Alzheimer’s disease and cognitive decline. Dement Geriatr Cogn Disord 22:296-00CrossRef PubMed 15.Feuk L, Prince JA, Breen G, Emahazion T, Carothers A, St Clair D et al (2000) apolipoprotein-E dependent role for the FAS receptor in early onset Alzheimer’s disease: finding of a positive association for a polymorphism in the TNFRSF6 gene. Hum Genet 107:391-96CrossRef PubMed 16.He XM, Zhang ZX, Zhang JW, Zhou YT, Tang MN, Wu CB et al (2006) The Fas gene A-670G polymorphism is not associated with sporadic Alzheimer disease in a Chinese Han population. Brain Res 1082:192-95CrossRef PubMed 17.Rosenmann H, Meiner Z, Kahana E, Aladjem Z, Friedman G, Ben-Yehuda A et al (2004) The Fas promoter polymorphism at position -670 is not associated with late-onset sporadic Alzheimer’s disease. Dement Geriatr Cogn Disord 17:143-46CrossRef PubMed 18.Theuns J, Feuk L, Dermaut B, Del-Favero J, Roks G, Van den Bossche D et al (2001) The TNFRSF6 gene is not implicated in familial early-onset Alzheimer’s disease. Hum Genet 108:552-53CrossRef PubMed 19.S-l Ma, Tang NLS, Lui VWC, Tam CWC, Lui VWC, Chiu HFK (2006) Lack of association between tumour necrosis factor receptor superfamily gene polymorphisms and the risk of Alzheimer’s disease in a Chinese population. Hong Kong J Psychiatry 16:128-31 20.Guo J, Jin M, Zhang M, Chen K (2012) A genetic variant in miR-196a2 increased digestive system cancer risks: a meta-analysis of 15 case-control studies. PLoS One 7:e30585PubMed Central CrossRef PubMed 21.Higgins JP, Thompson SG (2002) Quantifying heterogeneity in a meta-analysis. Stat Med 21:1539-558CrossRef PubMed 22.Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for publication bias. Biometrics 50:1088-101CrossRef PubMed 23.Egger M, Davey Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, graphical test. BMJ 315:629-34PubMed Central CrossRef PubMed 24.Kawai M, Kalaria RN, Harik SI, Perry G (1990) The relationship of amyloid plaques to cerebral capillaries in Alzheimer’s disease. Am J Pathol 137:1435-446PubMed Central PubMed 25.Yu W, Bonnet M, Farso M, Ma K, Chabot JG, Martin E et al (2014) The expression of apoptosis inducing factor (AIF) is associated with aging-related cell death in the cortex but not
作者单位:Jinlong Zhu (1) Jianhua Su (2) Ruiping Liu (3) (4) Jinsong Yang (5)
1. Nanjing Medical University, Nanjing, 210029, China 2. Department of Neurology, The Jintan Hospital Affiliated to Jiangsu University, Changzhou, 213200, China 3. Department of Orthopaedic Trauma, Changzhou Second People’s Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, 213003, China 4. Central Laboratory, Changzhou Second People’s Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, 213003, China 5. Department of Cerebral Surgery, Changzhou Second People’s Hospital, Affiliated Hospital of Nanjing Medical University, Changzhou, 213003, China
刊物主题:Geriatrics/Gerontology;
出版者:Springer International Publishing
ISSN:1720-8319
文摘
Backgrounds and aims The pathogenetic mechanism of Alzheimer’s disease (AD) is still unknown; however, gene polymorphism may play a critical role in the pathogenesis of AD. The aim of this meta-analysis was to evaluate the association between FAS gene A-670G polymorphism and AD.